In the next two to three years, Metropolis Healthcare wants to generate 60% of its income from B2C sales

 In the next two to three years, Metropolis Healthcare wants to generate 60% of its income from B2C sales

In the past three years, the diagnostic player has also seen price increases in the region of 4-5 percent.

In the next two to three years, Mumbai-based diagnostic services firm Metropolis Healthcare hopes to generate 60% of its sales from the business-to-consumer (B2C) market. 52% of the market is currently owned by the corporation.

Metropolis has been expanding its B2C market as it focuses on aggressive network growth. This encompasses over the years both the prescription-led business and direct customer test reservations.

Metropolis Healthcare's proprietor and managing director (MD), Ameera Shah, stated, "From FY17 to FY21, we expanded the B2C business from 37% to 50%. In the following two to three years, we hope to increase this to 60% of our sales.

Business-to-consumer (B2C) transactions provide margins that are at least 5–6% larger than those of the B2B sector.

According to Shah, the diagnostics company's main objective is to promote its B2C division, which is more lucrative and'sticky' than other divisions.

The core business sales increased by 12% year over year (YoY) in the first quarter of FY24, but overall revenues decreased as a result of the termination of a significant business-to-government contract. 

nonetheless, increased 13% YoY, and this rise was above 15% in Mumbai.

With speciality and wellness areas expanding by 15% and 19%, correspondingly, YoY, Metropolis has seen growth beyond test mix in B2C markets, the business reported following the first quarter results.

In order to broaden its network, it has been adding laboratories. The business wants to open 30 laboratories in India in FY24. This is comparable to the quantity of laboratories it added over the previous three years. Around 180 laboratories are owned by Metropolis nationwide. 

Metropolis Healthcare's CEO, Surendran Chemmenkotil, stated that in addition to lab growth, the business is also introducing collecting points. It would increase the 3,800 existing collecting centres by 800 this year.

According to Shah, the corporation has also raised prices by 4% to 5% on occasion during the past three years. He also mentioned that more specialty tests are being included in its repertoire.